v3.26.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Total Stockholders' Equity
Common Stock
Additional Paid In Capital
Distributions in Excess of Cumulative Earnings
Accumulated Other Comprehensive Loss
Non-controlling Interests
Beginning balance (in shares) at Dec. 31, 2024     187,537,592        
Beginning balance at Dec. 31, 2024 $ 3,572,127 $ 3,563,678 $ 1,875 $ 3,658,219 $ (113,302) $ 16,886 $ 8,449
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Common stock issuance and OP Unit issuance (in shares)     9,732,006        
Common stock issuance and OP Unit issuance 278,623 278,623 $ 97 278,526      
Common stock withheld related to net share settlement of equity awards (6,300) (6,300)     (6,300)    
Costs related to issuance of common stock (443) (443)   (443)      
Other comprehensive income (22,364) (22,295)       (22,295) (69)
Equity-based compensation expense (in shares)     242,718        
Equity-based compensation expense 3,968 3,968 $ 2 3,966      
Dividends and distributions declared (58,655) (58,368)     (58,368)   (287)
Net income 56,281 56,108     56,108   173
Ending balance (in shares) at Mar. 31, 2025     197,512,316        
Ending balance at Mar. 31, 2025 3,823,237 3,814,971 $ 1,974 3,940,268 (121,862) (5,409) 8,266
Beginning balance (in shares) at Dec. 31, 2024     187,537,592        
Beginning balance at Dec. 31, 2024 3,572,127 3,563,678 $ 1,875 3,658,219 (113,302) 16,886 8,449
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Other comprehensive income (34,780)            
Net income 119,651            
Ending balance (in shares) at Jun. 30, 2025     198,138,567        
Ending balance at Jun. 30, 2025 3,837,986 3,829,888 $ 1,981 3,963,899 (118,201) (17,791) 8,098
Beginning balance (in shares) at Mar. 31, 2025     197,512,316        
Beginning balance at Mar. 31, 2025 3,823,237 3,814,971 $ 1,974 3,940,268 (121,862) (5,409) 8,266
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Common stock issuance and OP Unit issuance (in shares)     604,104        
Common stock issuance and OP Unit issuance 20,186 20,186 $ 6 20,180      
Common stock withheld related to net share settlement of equity awards (7) (7)     (7)    
Costs related to issuance of common stock (45) (45)   (45)      
Other comprehensive income (12,416) (12,382)       (12,382) (34)
Equity-based compensation expense (in shares)     22,147        
Equity-based compensation expense 3,497 3,497 $ 1 3,496      
Dividends and distributions declared (59,836) (59,544)     (59,544)   (292)
Net income 63,370 63,212     63,212   158
Ending balance (in shares) at Jun. 30, 2025     198,138,567        
Ending balance at Jun. 30, 2025 $ 3,837,986 3,829,888 $ 1,981 3,963,899 (118,201) (17,791) 8,098
Beginning balance (in shares) at Dec. 31, 2025 209,702,433   209,702,433        
Beginning balance at Dec. 31, 2025 $ 4,207,894 4,199,994 $ 2,097 4,328,137 (109,261) (20,979) 7,900
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Common stock issuance and OP Unit issuance (in shares)     6,231,352        
Common stock issuance and OP Unit issuance 192,725 192,725 $ 62 192,663      
Common stock withheld related to net share settlement of equity awards (8,181) (8,181)     (8,181)    
Costs related to issuance of common stock (463) (463)   (463)      
Other comprehensive income 8,576 8,552       8,552 24
Equity-based compensation expense (in shares)     312,170        
Equity-based compensation expense 4,129 4,129 $ 3 4,126      
Dividends and distributions declared (67,576) (67,123)     (67,123)   (453)
Net income 59,950 59,792     59,792   158
Ending balance (in shares) at Mar. 31, 2026     216,245,955        
Ending balance at Mar. 31, 2026 $ 4,397,054 4,389,425 $ 2,162 4,524,463 (124,773) (12,427) 7,629
Beginning balance (in shares) at Dec. 31, 2025 209,702,433   209,702,433        
Beginning balance at Dec. 31, 2025 $ 4,207,894 4,199,994 $ 2,097 4,328,137 (109,261) (20,979) 7,900
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Other comprehensive income 19,359            
Net income $ 134,433            
Ending balance (in shares) at Jun. 30, 2026 216,271,958   216,271,958        
Ending balance at Jun. 30, 2026 $ 4,451,971 4,408,411 $ 2,163 4,527,700 (119,778) (1,674) 43,560
Beginning balance (in shares) at Mar. 31, 2026     216,245,955        
Beginning balance at Mar. 31, 2026 4,397,054 4,389,425 $ 2,162 4,524,463 (124,773) (12,427) 7,629
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Common stock issuance and OP Unit issuance 36,569           36,569
Costs related to issuance of common stock (93) (93)   (93)      
Other comprehensive income 10,781 10,753       10,753 28
Equity-based compensation expense (in shares)     26,003        
Equity-based compensation expense 3,331 3,331 $ 1 3,330      
Dividends and distributions declared (70,152) (69,292)     (69,292)   (860)
Net income $ 74,481 74,287     74,287   194
Ending balance (in shares) at Jun. 30, 2026 216,271,958   216,271,958        
Ending balance at Jun. 30, 2026 $ 4,451,971 $ 4,408,411 $ 2,163 $ 4,527,700 $ (119,778) $ (1,674) $ 43,560